Klaas de Boer
Chairman of the Board of Directors
Klaas has over 20 years of venture capital experience spanning Europe, North America and the Middle East. From 2006 to 2021, he was Managing Partner of Entrepreneurs Fund, where his portfolio included inge GmbH (sold to BASF), Technolas Perfect Vision (sold to Bausch + Lomb), Prosonix Ltd (sold to Circassia), Lifeline Scientific Inc (sold to Genext), NewMotion (sold to Shell) and Optinose (Nasdaq listing).
In addition to General Fusion, he currently chairs AIM-listed Xeros Technology Group and serves on the Boards of SmartKem and CelLBxHealth. Klaas is also an independent advisor of investment committee of the British Business Bank.
Klaas began his career with McKinsey & Company in Amsterdam. He subsequently joined Vanenburg Group, where he established and managed a corporate venturing team that led investments across Europe, Israel and the United States, including an investment in WebEx. Klaas holds an MSc in Applied Physics from Delft University of Technology and an MBA from Insead.
Join the Team
General Fusion is growing its team of engineers, scientists, operators, and professionals across disciplines, including business, finance, and operations, working on one of the most complex challenges in energy.